Maximum Strength Mucus Relief 1200 mg/1
Guaifenesin · TABLET, EXTENDED RELEASE · CHAIN DRUG MARKETING ASSOCIATION INC
Maximum Strength Mucus Relief is a tablet, extended release containing guaifenesin at 1200 mg/1, taken oral. Manufactured by CHAIN DRUG MARKETING ASSOCIATION INC.
Key Facts
- Brand Name
- Maximum Strength Mucus Relief
- Generic Name
- Guaifenesin
- NDC Code (Product)
63868-148- Manufacturer
- CHAIN DRUG MARKETING ASSOCIATION INC
- Strength
- 1200 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA213420
- Drug Class
- Expectorant [EPC]
- Marketing Start
- 09/17/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Maximum Strength Mucus Relief used for?
Maximum Strength Mucus Relief contains Guaifenesin. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is Maximum Strength Mucus Relief a controlled substance?
Maximum Strength Mucus Relief is not classified as a controlled substance by the DEA.
What is the generic name for Maximum Strength Mucus Relief?
The generic name for Maximum Strength Mucus Relief is Guaifenesin. There are 12 other brand versions of Guaifenesin.
What is the NDC code for Maximum Strength Mucus Relief 1200 mg/1?
The NDC (National Drug Code) for Maximum Strength Mucus Relief 1200 mg/1 is 63868-148, listed by CHAIN DRUG MARKETING ASSOCIATION INC.
Other Guaifenesin Brands
See all →- Guaifenesin and Dextromethorphan Hydrobromide10 mg/5mL72162-2277
- basic care mucus er600 mg/172288-298
- basic care mucus er max1200 mg/172288-613
- Pharbinex-DM20 mg/173057-381
- Mucus Relief DM Extended Release Caplets30 mg/10536-1161
- MUCUS RELIEF - DM MAXIMUM STRENGTH60 mg/173581-405
- BACZOL EXPECTORANT200 mg/5mL76864-209
- Guaifenesin and Pseudoephedrine HCl600 mg/179481-1002
- Meijer Adult Mucus Plus chest congestion200 mg/10mL79481-7430
- Tussin Mucus and Chest Congestion Sugar Free200 mg/10mL82568-0012
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)